DE2004869C2 - Verwendung einer in üblicher Weise gewonnenen i-RNS zur Antikörper-Bildung - Google Patents

Verwendung einer in üblicher Weise gewonnenen i-RNS zur Antikörper-Bildung

Info

Publication number
DE2004869C2
DE2004869C2 DE2004869A DE2004869A DE2004869C2 DE 2004869 C2 DE2004869 C2 DE 2004869C2 DE 2004869 A DE2004869 A DE 2004869A DE 2004869 A DE2004869 A DE 2004869A DE 2004869 C2 DE2004869 C2 DE 2004869C2
Authority
DE
Germany
Prior art keywords
acid
immunoribonucleic
antigen
injection
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2004869A
Other languages
German (de)
English (en)
Other versions
DE2004869A1 (de
Inventor
Susumu Musashino Tokyo Mitsuhashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of DE2004869A1 publication Critical patent/DE2004869A1/de
Application granted granted Critical
Publication of DE2004869C2 publication Critical patent/DE2004869C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE2004869A 1969-02-05 1970-02-03 Verwendung einer in üblicher Weise gewonnenen i-RNS zur Antikörper-Bildung Expired DE2004869C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP44008533A JPS4934804B1 (enrdf_load_stackoverflow) 1969-02-05 1969-02-05

Publications (2)

Publication Number Publication Date
DE2004869A1 DE2004869A1 (de) 1970-12-03
DE2004869C2 true DE2004869C2 (de) 1982-04-22

Family

ID=11695770

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2004869A Expired DE2004869C2 (de) 1969-02-05 1970-02-03 Verwendung einer in üblicher Weise gewonnenen i-RNS zur Antikörper-Bildung

Country Status (4)

Country Link
JP (1) JPS4934804B1 (enrdf_load_stackoverflow)
DE (1) DE2004869C2 (enrdf_load_stackoverflow)
FR (1) FR2051489B1 (enrdf_load_stackoverflow)
GB (1) GB1239354A (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843902B (zh) * 2010-05-21 2012-03-07 成都军区疾病预防控制中心军事医学研究所 一种中国陆生常见蝰科蛇毒多价抗血清的制备方法及用法

Also Published As

Publication number Publication date
JPS4934804B1 (enrdf_load_stackoverflow) 1974-09-18
FR2051489A1 (enrdf_load_stackoverflow) 1971-04-09
DE2004869A1 (de) 1970-12-03
GB1239354A (enrdf_load_stackoverflow) 1971-07-14
FR2051489B1 (enrdf_load_stackoverflow) 1974-07-12

Similar Documents

Publication Publication Date Title
DE2421083C2 (de) Impfstoffe und Verfahren zu ihrer Herstellung
AT408615B (de) Neue influenzavirus-impfstoffzusammensetzung
DE2049515C3 (de) Impfstoff gegen Vinishepatitis und Verfahren zu seiner Herstellung
DE2725204C2 (de) Verfahren zum Herstellen eines die unspezifische Immunität stimulierenden löslichen Mikroorganismenextrakts und diesem enthaltendes Arzneimittel
EP0413188B1 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oder IgA-haltige Immunglobulinpräparate
DE3911442A1 (de) Impfstoff-praeparation
DE69715031T2 (de) Azellulärer pertussis-impfstoff, der ein diphtherie-toxoid und ein tetanus-toxoid enthält
EP0085747B2 (de) Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
DE2301501A1 (de) Verfahren zur gewinnung eines stabilen, von hypotensiven stoffen freien plasmaproteins
DE2004869C2 (de) Verwendung einer in üblicher Weise gewonnenen i-RNS zur Antikörper-Bildung
DE2655691C2 (de) Temperaturempfindliche, vermehrungsfähige, nicht pathogene Varicella-Zoster-Viren, Verfahren zu ihrer Herstellung und diese Viren enthaltende Lebendvaccine
DE2323847C3 (de) Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion
DE2445819A1 (de) Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen
DE3122669A1 (de) "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
DE2823750B2 (de) Verfahren zur Gewinnung mindestens eines Hydrolyseprodukts eines Endotoxins von Bordetella Pertussis
DE2749961C2 (enrdf_load_stackoverflow)
Sabin Studies on the B virus. II: Properties of the virus and pathogenesis of the experimental disease in rabbits
DE1617545A1 (de) Antigenfreie Vaccine
DE1492243C3 (de) Injizierbare Impfstoffe
DE1902590C2 (de) Verwendung einer Immunribonucleinsäure (IRNS) zum Immunisieren lebender Tiere
DE2225548C3 (de) Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis
DE940315C (de) Verfahren zur Herstellung von Lymphe gegen Schweinepest
Verlinde An experimental study on problems of immunity and allergy in postvaccinal encephalitis
DE1966436C3 (de) Verwendung einer Antigen-Immunserum-Kombination als Impfstoff
DE2340911A1 (de) Tetanus-antigen und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
D2 Grant after examination
8339 Ceased/non-payment of the annual fee